Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Support for this work was provided by the organizational mandates of Public Health Ontario. Genome data acquisition and analysis was supported in part by grants from Genome Canada to NF and JTS under the umbrella of the Canadian COVID Genomics Network (CanCOGeN). JTS is also supported by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Public Health Ontario's Ethics Review Board has determined that this project is exempt from research ethics committee review, as it describes analyses that were completed at PHO Laboratory as part of routine clinical respiratory testing during the COVID-19 pandemic in Ontario and are therefore considered public health practice.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes